Inhibrx Biosciences (INBX) Interest Coverage Ratio (2023 - 2025)
Inhibrx Biosciences' (INBX) quarterly Interest Coverage Ratio came in at 5.32 in Q4 2025, up 78.84% year-on-year from 2.98 in Q4 2024, and down 25.79% on a QoQ basis from 4.23 in Q3 2025.
Inhibrx Biosciences (INBX) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Interest Coverage Ratio data on file, last reported at 5.32 in Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 78.84% year-over-year to 5.32 in Q4 2025; TTM through Dec 2025 was 10.23, a 52.1% increase from a year earlier, with the FY2025 full-year figure at 0.61, up 95.97% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 5.32, down from 4.23 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for INBX reached as high as 3.15 in Q2 2025 and fell as low as 29.8 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 10.29 across 3 years, with a median of 5.47 in 2025.
- Across the five-year window, Interest Coverage Ratio sank 469.77% in 2024 and surged 89.43% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 10.71 in 2023, then plunged by 134.75% to 25.15 in 2024, then jumped by 78.84% to 5.32 in 2025.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 5.32 in Q4 2025, 4.23 in Q3 2025, and 3.15 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Inhibrx Biosciences | 1.32 Bn | 1.32 Bn | - | -5.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.32 |
| Sep 30, 2025 | -4.23 |
| Jun 30, 2025 | -3.15 |
| Mar 31, 2025 | -4.64 |
| Dec 31, 2024 | -25.15 |
| Jun 30, 2024 | -29.80 |
| Mar 31, 2024 | -9.08 |
| Dec 31, 2023 | -10.71 |
| Sep 30, 2023 | -5.62 |
| Jun 30, 2023 | -5.23 |